Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: JAMA Neurol. 2013 Apr 1;70(4):448–454. doi: 10.1001/jamaneurol.2013.1033

Table 6.

Risk Factors for Symptomatic Epilepsy Among Survivors (n=67), Log-rank test

Risk Factor # with Epilepsy/# with Risk Factor # with Epilepsy/# without Risk Factor P Value Bonferroni corrected P Valuea
Seizure at presentation 4/29 5/38 .82
Acute seizure after presentation but <7 days 0/7 9/60 .58 1.00
Any acute symptomatic seizure within 7 days 4/33 5/34 .76
Childhood ICH 8/50 1/17 .04b .20
Cortical involvement 4/31 5/36 .60 1.00
Parenchymal location 9/60 0/7 .22
AED at discharge 5/36 4/31 .70
Epileptiform discharges 3/22 6/45 .47
Vascular malformation 6/35 3/32 .11 .55
Elevated ICP requiring urgent intervention 6/26 3/41 .007b .04c

Abbreviations: #, number; AED, antiseizure medication; ICP, intracranial pressure.

a

, Correction for a priori hypotheses only.

b

, Statistically significant prior to Boneferroni correction for multiple comparisons.

c

, Statistically significant after Bonferroni correction for multiple comparisons.